Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Collaborative Groups / G.I. and Other Associated Cancers Research Group / Discovered galectin-3 ligand as a serum biomarker of colon cancer

Discovered galectin-3 ligand as a serum biomarker of colon cancer

Discovered galectin-3 ligand as a serum biomarker of colon cancer with sensitivity 72% and specificity 80% based on blinded validation in standard reference set.

2015 Steering Committee Meeting

The next EDRN Steering Committee Meeting will take place March 31st through April 2nd, 2015, in Atlanta, Georgia.

Announcement 02/12/2015

Please register for the 29th EDRN Steering Committee Meeting in Atlanta, GA from March 31-April 2, 2015. The registration page has information about booking hotel rooms and a draft agenda of the meeting.

Announcement